Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 3, 2022
Accession Number: 0001193125-22-050259
Submission Type: POS AM
CIK: 0001560241
Company Name: G1 Therapeutics, Inc.
File Number: 333-257640